Anderson Kropman cc.， PO Box 1278， Parklands， Johannesburg， 2121， South Africa.OBJECTIVES: Heart failure (HF) is a serious， prevalent health condition in industrialised countries where the incidence has been on the.....
BACKGROUND: Several recent clinical trials have demonstrated that angiotensin II receptor blockers (ARBs) have cardiovascular as well as renal protective effects. Asian patients including Japanese were under-represented .....
K A A Fox， P A Poole-Wilson， R A Henderson， T C Clayton， D A Chamberlain， T R D Shaw， D J Wheatley， S J Pocock， for the Randomized Intervention Trial of unstable Angina (RITA) investigators*Summary.......
New Eng J Med.2005; Early release Intensive Lipid Lowering with Atorvastatinin Patients with Stable Coronary Disease John C. LaRosa， et al.Background ：Previous trials have demonst.....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context： Glucose-insulin-potassium (GIK) infusion is a widely applicable， low-cost therapy that has been postulated to improve mortality in pat.....
关注公众号
安卓客户端
